Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-25-024355

Director bought 93 shares at an average $4.48 ($417)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young Caroline Director 2025-04-01 Purchase 10b5-1 +4 $4.24 $17 32,396 D
Young Caroline Director 2025-04-02 Purchase 10b5-1 +4 $4.39 $18 32,400 D
Young Caroline Director 2025-04-03 Purchase 10b5-1 +4 $4.21 $17 32,404 D
Young Caroline Director 2025-04-04 Purchase 10b5-1 +4 $4.23 $17 32,408 D
Young Caroline Director 2025-04-07 Purchase 10b5-1 +4 $4.19 $17 32,412 D
Young Caroline Director 2025-04-08 Purchase 10b5-1 +4 $4.14 $17 32,416 D
Young Caroline Director 2025-04-09 Purchase 10b5-1 +4 $4.09 $16 32,420 D
Young Caroline Director 2025-04-10 Purchase 10b5-1 +4 $4.01 $16 32,424 D
Young Caroline Director 2025-04-11 Purchase 10b5-1 +4 $4.02 $16 32,428 D
Young Caroline Director 2025-04-14 Purchase 10b5-1 +5 $4.03 $20 32,433 D
Young Caroline Director 2025-04-15 Purchase 10b5-1 +5 $4.14 $21 32,438 D
Young Caroline Director 2025-04-16 Purchase 10b5-1 +5 $4.23 $21 32,443 D
Young Caroline Director 2025-04-17 Purchase 10b5-1 +5 $4.61 $23 32,448 D
Young Caroline Director 2025-04-21 Purchase 10b5-1 +5 $4.79 $24 32,453 D
Young Caroline Director 2025-04-22 Purchase 10b5-1 +5 $4.74 $24 32,458 D
Young Caroline Director 2025-04-23 Purchase 10b5-1 +5 $5.01 $25 32,463 D
Young Caroline Director 2025-04-24 Purchase 10b5-1 +5 $5.12 $26 32,468 D
Young Caroline Director 2025-04-25 Purchase 10b5-1 +5 $4.94 $25 32,473 D
Young Caroline Director 2025-04-28 Purchase 10b5-1 +4 $4.91 $20 32,477 D
Young Caroline Director 2025-04-29 Purchase 10b5-1 +4 $4.93 $20 32,481 D
Young Caroline Director 2025-04-30 Purchase 10b5-1 +4 $4.79 $19 32,485 D
Open-market purchases · 93 sh · avg $4.48 · $417
Loading xslF345X05/wk-form4_1746824709.xml…